These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


516 related items for PubMed ID: 33232910

  • 1. The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function.
    Ma L, Chen T, Zhang X, Miao Y, Tian X, Yu K, Xu X, Niu Y, Guo S, Zhang C, Qiu S, Qiao Y, Fang W, Du L, Yu Y, Wang J.
    Redox Biol; 2021 Jan; 38():101801. PubMed ID: 33232910
    [Abstract] [Full Text] [Related]

  • 2. Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma.
    Ma L, Zhang X, Yu K, Xu X, Chen T, Shi Y, Wang Y, Qiu S, Guo S, Cui J, Miao Y, Tian X, Du L, Yu Y, Xia J, Wang J.
    Free Radic Biol Med; 2021 May 20; 168():25-43. PubMed ID: 33785413
    [Abstract] [Full Text] [Related]

  • 3. The m6A Reader YTHDC2 Suppresses Lung Adenocarcinoma Tumorigenesis by Destabilizing MRPL12.
    Sun Y, Liu Y, Wang P, Chang L, Huang J.
    Mol Biotechnol; 2024 May 20; 66(5):1051-1061. PubMed ID: 38129673
    [Abstract] [Full Text] [Related]

  • 4. The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma.
    Ma L, Xue X, Zhang X, Yu K, Xu X, Tian X, Miao Y, Meng F, Liu X, Guo S, Qiu S, Wang Y, Cui J, Guo W, Li Y, Xia J, Yu Y, Wang J.
    J Exp Clin Cancer Res; 2022 Jan 25; 41(1):36. PubMed ID: 35078505
    [Abstract] [Full Text] [Related]

  • 5. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification.
    Xu Y, Lv D, Yan C, Su H, Zhang X, Shi Y, Ying K.
    Cancer Cell Int; 2022 Jan 07; 22(1):11. PubMed ID: 34996469
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of m6A Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-κB Pathway.
    Wang J, Tan L, Jia B, Yu X, Yao R, OUYang N, Yu X, Cao X, Tong J, Chen T, Chen R, Li J.
    Int J Biol Sci; 2021 Jan 07; 17(10):2633-2651. PubMed ID: 34326699
    [Abstract] [Full Text] [Related]

  • 7. Downregulation of m6 A reader YTHDC2 promotes tumor progression and predicts poor prognosis in non-small cell lung cancer.
    Sun S, Han Q, Liang M, Zhang Q, Zhang J, Cao J.
    Thorac Cancer; 2020 Nov 07; 11(11):3269-3279. PubMed ID: 32956555
    [Abstract] [Full Text] [Related]

  • 8. Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma.
    Hu K, Li K, Lv J, Feng J, Chen J, Wu H, Cheng F, Jiang W, Wang J, Pei H, Chiao PJ, Cai Z, Chen Y, Liu M, Pang X.
    J Clin Invest; 2020 Apr 01; 130(4):1752-1766. PubMed ID: 31874110
    [Abstract] [Full Text] [Related]

  • 9. Downregulation of the m6A reader YTHDC2 upregulates exosome content in lung adenocarcinoma via inhibiting IFIT and OAS family members.
    Yin Z, Ma L, Tian X, Sun Q, Zhang C, Wang Y, Miao Y, Xue X, Wang Y, Wang J, Zhang X, Hou X.
    J Biol Chem; 2024 Oct 01; 300(10):107783. PubMed ID: 39303913
    [Abstract] [Full Text] [Related]

  • 10. N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
    Teng Y, Zhao X, Xi Y, Fu N.
    Cancer Biol Ther; 2023 Dec 31; 24(1):2249173. PubMed ID: 37700507
    [Abstract] [Full Text] [Related]

  • 11. [LIM-domain binding protein 2 regulated by m6A modification inhibits lung adenocarcinoma cell proliferation in vitro].
    Zhai D, Wang G, Li L, Jia X, Zheng G, Yin J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar 25; 41(3):329-335. PubMed ID: 33849822
    [Abstract] [Full Text] [Related]

  • 12. KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/ MAPK pathway in an m6A-dependent manner.
    Lin X, Ye R, Li Z, Zhang B, Huang Y, Du J, Wang B, Meng H, Xian H, Yang X, Zhang X, Zhong Y, Huang Z.
    Drug Resist Updat; 2023 Jan 25; 66():100908. PubMed ID: 36493511
    [Abstract] [Full Text] [Related]

  • 13. The m6A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5'-3' exoribonuclease XRN1.
    Kretschmer J, Rao H, Hackert P, Sloan KE, Höbartner C, Bohnsack MT.
    RNA; 2018 Oct 25; 24(10):1339-1350. PubMed ID: 29970596
    [Abstract] [Full Text] [Related]

  • 14. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma.
    Zhang X, Yu K, Ma L, Qian Z, Tian X, Miao Y, Niu Y, Xu X, Guo S, Yang Y, Wang Z, Xue X, Gu C, Fang W, Sun J, Yu Y, Wang J.
    Theranostics; 2021 Oct 25; 11(12):5650-5674. PubMed ID: 33897873
    [Abstract] [Full Text] [Related]

  • 15. N6 -Methyladenosine Reader Protein YT521-B Homology Domain-Containing 2 Suppresses Liver Steatosis by Regulation of mRNA Stability of Lipogenic Genes.
    Zhou B, Liu C, Xu L, Yuan Y, Zhao J, Zhao W, Chen Y, Qiu J, Meng M, Zheng Y, Wang D, Gao X, Li X, Zhao Q, Wei X, Wu D, Zhang H, Hu C, Zhuo X, Zheng M, Wang H, Lu Y, Ma X.
    Hepatology; 2021 Jan 25; 73(1):91-103. PubMed ID: 32150756
    [Abstract] [Full Text] [Related]

  • 16. The biological function of the N6-Methyladenosine reader YTHDC2 and its role in diseases.
    Wu X, Chen H, Li K, Zhang H, Li K, Tan H.
    J Transl Med; 2024 May 24; 22(1):490. PubMed ID: 38790013
    [Abstract] [Full Text] [Related]

  • 17. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway.
    Yu C, Tian F, Liu J, Su M, Wu M, Zhu X, Qian W.
    Cell Prolif; 2019 May 24; 52(3):e12610. PubMed ID: 31012177
    [Abstract] [Full Text] [Related]

  • 18. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
    Han S, Cao D, Sha J, Zhu X, Chen D.
    Mol Oncol; 2020 May 24; 14(5):1074-1088. PubMed ID: 31919993
    [Abstract] [Full Text] [Related]

  • 19. Regulation of m6A Transcripts by the 3'→5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline.
    Wojtas MN, Pandey RR, Mendel M, Homolka D, Sachidanandam R, Pillai RS.
    Mol Cell; 2017 Oct 19; 68(2):374-387.e12. PubMed ID: 29033321
    [Abstract] [Full Text] [Related]

  • 20. The N6-methyladenosine reader protein YTHDC2 promotes gastric cancer progression via enhancing YAP mRNA translation.
    Yuan W, Chen S, Li B, Han X, Meng B, Zou Y, Chang S.
    Transl Oncol; 2022 Feb 19; 16():101308. PubMed ID: 34911015
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.